Score Overview
AnaptysBio Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 75M to $ 234M and net income went from -$ 19M to -$ 13M. Revenue increased in 3 of those 5 years; net income in 2.
Across AnaptysBio Inc's full reported history, from 2017 to 2025, revenue grew from $ 10M to $ 234M and net income went from -$ 30M to -$ 13M. Revenue increased in 56% of the years measured; net income in 33%.
AnaptysBio Inc currently holds a 5-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 56.98 | — |
1 Year2025-08-12 | $ 13.41 | 325.01% |
5 Years2021-08-12 | $ 15.87 | 258.97% |
All Time2017-01-26 | $ 11.33 | 402.77% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2017-01-26 |
|---|---|---|---|---|
| Price | $ 56.98 | $ 13.41 | $ 15.87 | $ 11.33 |
| Return | — | 325.01% | 258.97% | 402.77% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 232M | -$ 26M | $ 286M |
| 2025 | $ 234M | -$ 13M | $ 311M |
| 2024 | $ 91M | -$ 145M | $ 385M |
| 2023 | $ 17M | -$ 163M | $ 390M |
| 2022 | $ 10M | -$ 128M | $ 441M |
| 2021 | $ 63M | -$ 57M | $ 548M |
| 2020 | $ 75M | -$ 19M | $ 393M |
| 2019 | $ 8M | -$ 97M | $ 374M |
| 2018 | $ 5M | -$ 61M | $ 427M |
| IPO2017 | $ 10M | -$ 30M | $ 248M |
Explore beyond ANAB
You're looking at AnaptysBio Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
